Gemcabene Calcium

N/A

Report date: 2023/11/30 16:56:41
NME

Base Information

Drug NameGemcabene Calcium
Drug Alias Namegemcabenum吉卡宾gemcabenoPD-072953CI-1027 +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator activated receptor agonists
TargetsPeroxisome proliferator activated receptor
Therapy Area/IndicationsHypertriglyceridemiaHypercholesterolemiaDyslipidemias +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesIsrael
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGemphire Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypertriglyceridemiaHypercholesterolemiaDyslipidemias +[5

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG